FI946006A - Multimeric forms of human rhinovirus receptor protein - Google Patents

Multimeric forms of human rhinovirus receptor protein Download PDF

Info

Publication number
FI946006A
FI946006A FI946006A FI946006A FI946006A FI 946006 A FI946006 A FI 946006A FI 946006 A FI946006 A FI 946006A FI 946006 A FI946006 A FI 946006A FI 946006 A FI946006 A FI 946006A
Authority
FI
Finland
Prior art keywords
receptor protein
human rhinovirus
multimeric forms
rhinovirus receptor
multimeric
Prior art date
Application number
FI946006A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI946006A0 (en
Inventor
Jeffrey M Greve
Alan Mcclelland
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of FI946006A publication Critical patent/FI946006A/en
Publication of FI946006A0 publication Critical patent/FI946006A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/085Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • C07K14/095Rhinovirus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70525ICAM molecules, e.g. CD50, CD54, CD102
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/08Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI946006A 1992-06-22 1994-12-21 Multimeric forms of human rhinovirus receptor protein FI946006A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90306992A 1992-06-22 1992-06-22
PCT/US1993/005972 WO1994000485A1 (en) 1992-06-22 1993-06-22 Multimeric forms of human rhinovirus receptor protein

Publications (2)

Publication Number Publication Date
FI946006A true FI946006A (en) 1994-12-21
FI946006A0 FI946006A0 (en) 1994-12-21

Family

ID=25416893

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946006A FI946006A0 (en) 1992-06-22 1994-12-21 Multimeric forms of human rhinovirus receptor protein

Country Status (10)

Country Link
EP (1) EP0604624A4 (en)
JP (1) JPH06510208A (en)
KR (1) KR950702576A (en)
AU (1) AU675441B2 (en)
CA (1) CA2116109A1 (en)
FI (1) FI946006A0 (en)
HU (1) HUT75827A (en)
NO (1) NO944966L (en)
RU (1) RU94046450A (en)
WO (1) WO1994000485A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (en) 1988-09-01 2000-03-16 Bayer Ag HUMAN RHINOVIRUS RECEPTOR PROTEIN INHIBITING VIRUS INFECTIVITY.
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9520641D0 (en) * 1995-10-10 1995-12-13 Medical Res Council Improvements in or relating to protection against intracellular infection
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
BR112014024398B1 (en) * 2012-03-31 2022-03-08 R-Pharm International, Llc POLYPEPTIDE BINDING HUMAN RANKL, THERAPEUTIC COMPOSITIONS COMPRISING SAID POLYPEPTIDE, ISOLATED NUCLEIC ACID, EXPRESSION VECTOR AND THERAPEUTIC USE OF SAID POLYPEPTIDE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0606518B1 (en) * 1988-09-28 2003-07-30 Dana Farber Cancer Institute Intercellular adhesion molecules and their binding ligands
EP0387701B1 (en) * 1989-03-09 1992-08-12 Boehringer Ingelheim Pharmaceuticals Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein

Also Published As

Publication number Publication date
AU675441B2 (en) 1997-02-06
EP0604624A4 (en) 1997-03-12
JPH06510208A (en) 1994-11-17
NO944966D0 (en) 1994-12-21
CA2116109A1 (en) 1994-01-06
HUT75827A (en) 1997-05-28
KR950702576A (en) 1995-07-29
AU4543293A (en) 1994-01-24
WO1994000485A1 (en) 1994-01-06
NO944966L (en) 1994-12-21
RU94046450A (en) 1996-10-10
FI946006A0 (en) 1994-12-21
EP0604624A1 (en) 1994-07-06
HU9403720D0 (en) 1995-02-28

Similar Documents

Publication Publication Date Title
FI935175A0 (en) Tyrosine-HER4 human receptor
DK0605442T3 (en) Recombinant antibodies for human therapy
NO973404D0 (en) Human interleukin-1 receptor accessory protein
DE69629988D1 (en) Basic pharmaceutical ingredient and its use
FI974432A (en) Use of Gram-positive bacteria for expression of recombinant proteins
NO980915D0 (en) Recombinant anti-CD4 antibody suitable for human therapy
ID22216A (en) USE OF CENTRANAN CANAGINOID ANTAGONISTS RECEPTORS TO CONTROL FOOD TREATMENT
NO991162D0 (en) Monoclonal antibodies to the extracellular domain of human VEGF receptor protein (KDR)
DE69807466D1 (en) TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
EE9700168A (en) Bicyclic isothiourea derivatives for therapeutic use
NO932391D0 (en) ANGIOTENSIN-II RECEPTOR ANTAGONISTS FOR TREATMENT OF HEART RHYTHMY DISORDERS
FI946006A (en) Multimeric forms of human rhinovirus receptor protein
EE9700207A (en) Bicyclic amidine derivatives for therapeutic use
NO981822D0 (en) Use of the GAX protein for the treatment of cancer
NO980375D0 (en) Human MP52 Arg protein
DK442189A (en) HUMAN RHINOVIRUS Peptides
DE69228669D1 (en) PROTEIN SEQUENCING
AU652567C (en) Multimeric form of human rhinovirus receptor protein
AU7174696A (en) Multimeric forms of human rhinovirus receptor protein
NO982734L (en) Process for Purification of Recombinant Human Interleukin-8
DE69320154D1 (en) Human id genes
NO179147C (en) Fish Trapp Construction
KR970012810U (en) Upper angle control device of backrest
IE892805L (en) Human rhinovirus receptor protein
BR9503121A (en) Improvement of orthopedic pacifier

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: BAYER CORPORATION